Table 3 Presence of postdromal symptoms and risk factors
Simple Logistic Regression (Univariate) | Binomial Logistic Regression (Multivariate) | |||
|---|---|---|---|---|
Odds Ratio (95% CI) | P-value | Odds Ratio (95% CI) | P-value | |
Age | 1.01 (0.99–1.02) | 0.21 | ||
Female | 2.22(1.26–3.81) | 0.005 | 2.09 (1.08–3.96) | 0.03 |
Migraine With Aura | 1.32 (0.86–2.09) | 0.22 | ||
Chronic Migraine | 0.80 (0.52–1.22) | 0.31 | ||
Medication-Overuse Headache | 0.97 (0.64–1.47) | 0.87 | ||
Monthly Migraine Days | 0.91 (0.89–0.94) | < 0.001 | 0.94 (0.91–0.97) | < 0.001* |
Migraine Duration | 1.00 (0.998–1.01) | 0.15 | ||
Migraine Intensity (NRS score) | 1.06 (0.93–1.22) | 0.37 | ||
Current Use of Triptans as Acute Treatment | 2.10 (1.15–3.72) | 0.013 | 1.14 (0.55–2.28) | 0.72 |
Current Use of Preventive Medication | 1.37 (0.92–2.04) | 0.12 | ||
Presence of Premonitory Symptoms | 10.66 (6.83–16.97) | < 0.001 | 8.77 (5.53–14.14) | < 0.001* |
Presence of Trigger Factors | 1.70 (0.65–4.00) | 0.25 | ||